RBC Capital analyst Ken Herbert lowered the firm’s price target on Northrop Grumman to $520 from $550 and keeps an Outperform rating on the shares. The company’s strong Q4 sales and earnings did not fully translate to margins and free cash flow, the analyst tells investors in a research note. The management also addressed the B-21 margin questions as the program starts to transition to LRIP, which could be a margin headwind, the firm adds, though RBC Capital maintains a favorable view on the stock based on its defense exposure.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on NOC:
- Northrop Grumman Receives Analyst Downgrade, Shares Slide
- Northrop Grumman price target lowered to $535 from $615 at Susquehanna
- Northrop Grumman price target lowered to $500 from $540 at Credit Suisse
- Northrop Grumman downgraded to Market Perform from Outperform at Cowen
- Northrop Grumman says ‘performing exceptionally well’ on B-21 program